Incentives for Global Health

Incentives for Global Health

The Health Impact Fund, "our flagship proposal, is a new way of stimulating research and development of life-saving pharmaceuticals. To provide wide access, medicines need to be affordable-but low prices don't create strong incentives for innovators to invest in research and development. The Health Impact Fund is an optional mechanism that offers pharmaceutical innovators a supplementary reward based on the health impact of their products, if they agree to sell those products at cost. The proposed Fund is to be financed mainly by governments."

Support and Affiliations:


 * Australian Research Council
 * BUPA Foundation, UK
 * Centre for Applied Philosophy and Public Ethics (CAPPE), Australian National University
 * Gilberts LLP, Canada

Management Team
Accessed February 2010:


 * Thomas Pogge, President, Director
 * Aidan Hollis, Vice President, Director
 * Tim Gilbert, Director
 * Matt Peterson, Chief Financial Officer
 * Dave Goodman, Secretary
 * David Franklin, Pro Bono Legal Advisor
 * Surjeet Ahluwalia, Senior Project Manager

Advisory Board
Accessed February 2010:


 * John J. DeGioia
 * Ruth Faden
 * Paul Farmer
 * Jim Yong Kim
 * Christopher Murray
 * Onora O'Neill
 * James Orbinski
 * Sir Michael Rawlins
 * Amartya Sen
 * Peter Singer
 * Judith Whitworth
 * Heidemarie Wieczorek-Zeul
 * Richard Wilder

Contact
URL: http://www.yale.edu/macmillan/igh/